Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.

Front Med (Lausanne)

Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Department of Pharmacology, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.

Published: September 2021

AI Article Synopsis

  • Evidence suggests that gut microbiota imbalances worsen diabetic kidney disease (DKD), and prebiotics can help restore balance and reduce inflammation.
  • The Traditional Chinese Medicine formula Qing-Re-Xiao-Zheng (QRXZF) shows promise for treating DKD, but its impact on gut microbiota regulation is not fully understood.
  • In a study using DKD mice models, QRXZF treatment resulted in improved kidney function, reduced inflammation, and enhanced gut barrier integrity, indicating its potential effectiveness through modulation of gut microbiota and inflammatory pathways.

Article Abstract

Evidence indicates that the metabolic inflammation induced by gut microbiota dysbiosis contributes to diabetic kidney disease. Prebiotic supplementations to prevent gut microbiota dysbiosis, inhibit inflammatory responses, and protect the renal function in DKD. Qing-Re-Xiao-Zheng formula (QRXZF) is a Traditional Chinese Medicine (TCM) formula that has been used for DKD treatment in China. Recently, there are growing studies show that regulation of gut microbiota is a potential therapeutic strategy for DKD as it is able to reduce metabolic inflammation associated with DKD. However, it is unknown whether QRXZF is effective for DKD by regulating of gut microbiota. In this study, we investigated the reno-protective effect of QRXZF by exploring its potential mechanism between gut microbiota and downstream inflammatory pathways mediated by gut-derived lipopolysaccharide (LPS) in the kidney. High-fat diet (HFD) and streptozotocin injection-induced DKD mice model was established to assess the QRXZF effect . Mice treated with QRXZF for 8 weeks had significantly lower levels of urinary albumin, serum cholesterol and triglycerides. The renal injuries observed through histological analysis were attenuated as well. Also, mice in the QRXZF group had higher levels of Zonula occludens protein-1 (ZO-1) expression, lower levels of serum fluorescein-isothiocyanate (FITC)-dextran and less-damaged colonic mucosa as compared to the DKD group, implying the benefit role for the gut barrier integrity. QRXZF treatment also reversed gut dysbiosis and reduced levels of gut-derived LPS. Notably, the expression of toll-like receptor 4 (TLR4) and nuclear factor-κB (NF-κB), which are important inflammation pathways in DKD, were suppressed in the QRXZF groups. In conclusion, our results indicated that the reno-protective effects of QRXZF was probably associated with modulating gut microbiota and inhibiting inflammatory responses in the kidney.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481597PMC
http://dx.doi.org/10.3389/fmed.2021.719950DOI Listing

Publication Analysis

Top Keywords

gut microbiota
28
gut
9
qrxzf
9
qing-re-xiao-zheng formula
8
diabetic kidney
8
kidney disease
8
metabolic inflammation
8
microbiota dysbiosis
8
inflammatory responses
8
dkd
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!